BCR and B-cell chronic lymphocytic leukemia: The IGHV1-69 BCR allelic variants expressed in B-CLL cells predominantly use a phenylalanine at position 54 (F54) of the heavy chain complementarity determining region 2 (HCDR2) [18], [19] and the estimated global frequency of F54 is 60% [20].